About

Dr. Alessandro Lucidi is a leading figure in the advancement of robotic gynecologic oncology, with a focused expertise in minimally invasive surgical approaches for complex pelvic malignancies. His work has been pivotal in demonstrating the safety and efficacy of robotic surgery for high-risk populations, most notably through his multicenter study on robotic hysterectomy in severely obese patients with endometrial cancer (37 citations). Dr. Lucidi has also made significant contributions to the management of locally advanced cervical cancer, authoring a prospective Phase II study on robotic radical hysterectomy following chemoradiation (28 citations), and has rigorously compared robotic versus laparoscopic techniques for early-stage disease in a case-control study (19 citations). Beyond technical innovation, he is a pioneer in patient safety, drawing from aviation models to develop error-reduction protocols for robotic gynecologic surgery—a field he identifies as a top health hazard. With over 100 combined citations across his most influential works, Dr. Lucidi’s research not only expands surgical frontiers but also champions a culture of safety, making him a vital voice in the evolution of modern gynecologic oncology.

Research Focus

Key Achievements

4
H-Index
5
Papers
102
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Hysterectomy in Severely Obese Patients With Endometrial Cancer: A Multicenter Study
37 citations · 2015
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 31
🏛 Institutions: Università Cattolica del Sacro Cuore, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo, University of Palermo, University of Chieti-Pescara

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago